These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19262684)

  • 1. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.
    Michelsen KS; Thomas LS; Taylor KD; Yu QT; Mei L; Landers CJ; Derkowski C; McGovern DP; Rotter JI; Targan SR
    PLoS One; 2009; 4(3):e4719. PubMed ID: 19262684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFSF15 is an ethnic-specific IBD gene.
    Picornell Y; Mei L; Taylor K; Yang H; Targan SR; Rotter JI
    Inflamm Bowel Dis; 2007 Nov; 13(11):1333-8. PubMed ID: 17663424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease.
    Richard AC; Peters JE; Savinykh N; Lee JC; Hawley ET; Meylan F; Siegel RM; Lyons PA; Smith KGC
    PLoS Genet; 2018 Sep; 14(9):e1007458. PubMed ID: 30199539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells.
    Prehn JL; Thomas LS; Landers CJ; Yu QT; Michelsen KS; Targan SR
    J Immunol; 2007 Apr; 178(7):4033-8. PubMed ID: 17371957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
    Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort.
    Thiébaut R; Kotti S; Jung C; Merlin F; Colombel JF; Lemann M; Almer S; Tysk C; O'Morain M; Gassull M; Binder V; Finkel Y; Pascoe L; Hugot JP
    Am J Gastroenterol; 2009 Feb; 104(2):384-91. PubMed ID: 19174806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverticulitis and Crohn's disease have distinct but overlapping tumor necrosis superfamily 15 haplotypes.
    Connelly TM; Choi CS; Berg AS; Harris L; Coble J; Koltun WA
    J Surg Res; 2017 Jun; 214():262-269. PubMed ID: 28624054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.
    Lan X; Lan X; Chang Y; Zhang X; Liu J; Vikash V; Wang W; Huang M; Wang X; Zhou F; Chen L; Zhao Q
    Cell Physiol Biochem; 2017; 41(5):2077-2090. PubMed ID: 28456797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
    Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
    J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
    Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
    Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis.
    Shih DQ; Barrett R; Zhang X; Yeager N; Koon HW; Phaosawasdi P; Song Y; Ko B; Wong MH; Michelsen KS; Martins G; Pothoulakis C; Targan SR
    PLoS One; 2011 Jan; 6(1):e16090. PubMed ID: 21264313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease.
    Furfaro F; Alfarone L; Gilardi D; Correale C; Allocca M; Fiorino G; Argollo M; Zilli A; Zacharopoulou E; Loy L; Roda G; Danese S
    Curr Drug Targets; 2021; 22(7):760-769. PubMed ID: 33475057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR8-mediated activation of human monocytes inhibits TL1A expression.
    Saruta M; Michelsen KS; Thomas LS; Yu QT; Landers CJ; Targan SR
    Eur J Immunol; 2009 Aug; 39(8):2195-202. PubMed ID: 19637197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.